Showing results (161-170 of 238) with videos related to
Sort By:
Pageof 24
Journal of the American College of Cardiology|June 27, 2009
Interventional and surgical modalities of treatment in pulmonary hypertensionAnne M Keogh, Eckhard Mayer, Raymond L Benza, et al.Heart, Lung & Circulation|March 20, 2013
Death on an LVAD-Two sides of a coinJustin A K Phan, Kavitha Muthiah, Desiree Robson, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2006
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter studyJon A Kobashigawa, Dale G Renlund, Gino Gerosa, et al.AIDS (London, England)|July 17, 2007
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART eraTisha Joy, Hester M Keogh, Colleen Hadigan, et al.Heart, Lung & Circulation|April 11, 2024
Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care SystemJim Pouliopoulos, Chris Anthony, Muhammad Imran, et al.Diabetes|April 30, 2003
Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populationsChiao-Chien Connie Hung, I Sadaf Farooqi, Ken Ong, et al.Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 14, 2017
Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 studyNazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, et al.Iscience|June 1, 2023
Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson's diseaseAnthony L Gaeta, Karolina Willicott, Corey W Willicott, et al.The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of pulmonary arterial hypertensionHossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, et al.Pageof 24